• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTCX:US

21.68 USD 0.85 4.08%

As of 09:29:30 ET on 12/17/2014.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTCX)

Year To Date: +31.83% 3-Month: +11.32% 3-Year: +45.19% 52-Week Range: 15.42 - 22.29
1-Month: +6.60% 1-Year: +39.67% 5-Year: +31.40% Beta vs MXWO: 1.12

Mutual Fund Chart for FBTCX

No chart data available.
  • FBTCX:US 21.68
  • 1M
  • 1Y
Interactive FBTCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTCX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTCX

NAV (on 2014-12-17) 21.68
Assets (M) (on 2014-11-28) 2,086.30
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTCX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-12) 0.42
Dividend Yield (ttm) 2.79

Fees & Expenses for FBTCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 1.00
Expense Ratio 1.83

Top Fund Holdings for FBTCX

Filing Date: 10/31/2014
Name Position Value % of Total
Gilead Sciences Inc 2,341,830 262,284,960 13.410%
Celgene Corp 1,358,711 145,504,361 7.439%
Vertex Pharmaceuticals Inc 904,326 101,863,281 5.208%
Alexion Pharmaceuticals Inc 503,799 96,406,977 4.929%
Regeneron Pharmaceuticals Inc 221,200 87,090,864 4.453%
Puma Biotechnology Inc 219,658 55,046,295 2.814%
Amgen Inc 320,517 51,981,447 2.658%
Medivation Inc 431,077 45,564,839 2.330%
BioMarin Pharmaceutical Inc 546,637 45,097,553 2.306%
Intercept Pharmaceuticals Inc 168,060 43,425,023 2.220%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil